2024 annual financial data
Liminatus Pharma 2024 Operating margin
Liminatus Pharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -2,906,319 USD and net income was -2,904,299 USD.
Operating cash flow was -3,106,462 USD.
Get free Liminatus Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -2,906,319 USD
- Net income
- -2,904,299 USD
- Operating cash flow
- -3,106,462 USD